期刊文献+

别嘌呤醇治疗慢性心力衰竭合并高尿酸血症的疗效观察 被引量:2

To Observe the Effects Allopurinol on Cardiac Function and Serum Uric Acid in Hyperuricemic Patients with Chronic Heart Failure
下载PDF
导出
摘要 目的:探讨别嘌呤醇治疗慢性心力衰竭合并高尿酸血症患者的疗效。方法:选择2009-12~2012-02在我院住院的慢性心力衰竭患者血尿酸增高的患者68例,随机分为治疗组36例和对照组32例,治疗组和对照组均通过查房随访和健康讲座提倡合理的生活方式和心衰规范化药物治疗。治疗组给与别嘌呤醇(0.25 g),1次/d。随访3个月后观察两组患者血清中血尿酸水平的变化和随访期心功能(NYHA)分级及超声心动图中心功能指数的变化情况。结果:治疗组在3个月治疗后血清血尿酸水平明显下降(P<0.05),对照组血清中血尿酸水平无明显变化。随访期间对照组心功能NYHA分级变化总有效率为85.3%,治疗组为60.8%,两组之间有统计学差异(P<0.05);治疗组治疗前后超声心动图中左室射血分数(LVEF)明显增高及左室舒张末期内径(LVEDD)明显降低,两组之间有统计学差异(P<0.05)。结论:别嘌呤醇治疗伴有血尿酸增高的慢性心力衰竭患者可以显著降低患者血清中血尿酸水平,同时有效改善心功能。 Objective:To observe the effects allopurinol on cardiac function and serum uric acid in hyperuricemic patients with chronic heart failure. Methods :98 hyperuricemic patients with chronic heart failure were randomly divided in two groups. All patients in the two groups were given the routine treatment with antihypertensive drug and healthy education lecture. 36patients in the treatment group were given oral allopurinol (250 mg) once a day for 3 monthsin addition to the standard anti - heart failure treatment. Compare the change between the serum uric acid level, the level of cardiac function with NYHA an, Left Ventrieular Ejiect Fraction (LVEF) and Left Ventricular End -diastolic Diameter (LVEDD). Results:In the allopurinol treatment group the serum uric acid decreased (P 〈 0. 05) ; LVEDD shrinked (P 〈 0.05 ) and LVEF increased ( P 〈 0. 05 ) significantly. Conclusions: The treatment of fixed combination of allopurinol patients can reduced the level of serum uric acid and improve cardiac funtion in patients with chronic heart failure markedly.
出处 《航空航天医学杂志》 2012年第5期517-520,共4页 Journal of Aerospace medicine
关键词 别嘌呤醇 高尿酸血症 慢性心力衰竭 allopurinol hyperuricemic chronic heart diease
  • 相关文献

参考文献8

  • 1顾东风,黄广勇,吴锡桂,段秀芳,何江,Paul K Whelton,Stephen Mac Mahon.中国心力衰竭流行病学调查及其患病率[J].中华心血管病杂志,2003,31(1):3-6. 被引量:1279
  • 2Pascual-Figal DA,Hurtado-Martinez JA,Redondo B,et al.Hyperuricaemia and long-term outcome after hospital dischange in acute heart failure patients.Eur J Heart Fail,2007,9(5):518-524.
  • 3Leyva F,Anker SD,Swan JW,et al.Serum uric acid as index of impaired oxidative metabolism in chronic heart failure.Eur Heart J,1997,18(5):858-865.
  • 4木胡牙提,邓勤,马依彤,张源明,程祖亨.慢性心力衰竭患者B型利钠肽与尿酸的变化及意义[J].中国循环杂志,2009,24(4):267-269. 被引量:12
  • 5Struthers AD,Donnan PT,Lindsay P,et al.Effect of allopurnol on motality and hospitalizations in chronic heart failure:a retrospective cohort study[J].Heart,2002,87(17):229-234.
  • 6邢海燕,轩楠,宋丽萍.别嘌呤醇在心血管疾病诊治中的应用[J].中国心血管病研究,2008,6(2):146-148. 被引量:15
  • 7Anker SD,Doehner W,Rauchhaus M.et al.Uric acid and survival in chronic heart failure:validation and application in metabolic,functional,and hemodynamic staging[J].Circulation,,2003,107:1991-1997.
  • 8Ulfece,Robert WH.Oris,et al.Intravenous allopurinol dacreases mvocardial oxygen consumption and increases mechanical effeciency in dogs with pacing-induced heart failure[J].Circulation Res,1999,85(5):437-445.

二级参考文献25

  • 1肖立中,江志平,黄志,徐新,潘丽坤,赖少燕,曾兆俞.别嘌醇对充血性心力衰竭患者心功能的影响[J].心脏杂志,2004,16(5):452-453. 被引量:11
  • 2郭丽,张丽,曲红玉,高山.老年心力衰竭患者血清尿酸水平变化的临床分析[J].心血管康复医学杂志,2007,16(2):131-133. 被引量:7
  • 3Michael W, Christin H. Role of B-type natriuretic peptide (BNP) and NT-proBNP in clinical routine. Heart,2006,92 (6) :843-849.
  • 4Williams SG,Ng LL, Obrien R J, et al. Complementary roles of simple variable, NYHA and N-BNP,in indicating aerobic capacity and severity of heart failure. Int J Cardiol,2005,102 ( 2 ) :279-286.
  • 5Kuster GM,Tanner H, Printzen G, et al. B-type natriuretic Peptide for diagnosis and treatment of congestive heart failure. Swiss Med Wkly, 2002,132(43-44) :623-628.
  • 6Ohuchi H, Takasugi H, Ohashi H, et al. Stratification of pediatric heart failure on the basis of neurohormonal and cardiac autonomic nervous activities in patients with congenital heart disease. Circulation, 2003, 108 (19) : 2368-2376.
  • 7Kawai K, Hata K,Tataok H, et al. Plasma BNP as novel therapentic indicator in idiopathic dilated cardiomyopathy during β-blocker therapy:A potential of hormone-guided treatment. Am Heart J,2001,141 : 925-932.
  • 8Leyva F,Ankers, Swan JW, et al. Serum uric acid as an index of impaired oxidative metabolism in chronic heart failure. Eur Heart J, 1997,18(5) :858-865.
  • 9[2]Masuo K,Kawaguchi H,Mikami H,et al.Serum uric acid and plasma norepinephrine concentrations predict subsequent weight gain and blood pressure elevation.Hypertension,2003,42:474-480.
  • 10[3]Toda N,Kitamura Y,Okamura T.Neural mechanic of hypertension by nitric oxide synthesis inhibitor in dogs.Hypertension,1993,21:3.

共引文献1301

同被引文献29

引证文献2

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部